The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Leca, G.
Right arrow Articles by Bensussan, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Leca, G.
Right arrow Articles by Bensussan, A.

The Journal of Immunology, Vol 154, Issue 3 1069-1077, Copyright © 1995 by American Association of Immunologists


ARTICLES

Expression of VCAM-1 (CD106) by a subset of TCR gamma delta-bearing lymphocyte clones. Involvement of a metalloprotease in the specific hydrolytic release of the soluble isoform

G Leca, SE Mansur and A Bensussan
Association Claude Bernard, Saint Louis Hospital, Paris, France.

The cytokine-inducible vascular cell adhesion molecule 1/CD106 is widely distributed in endothelial, epithelial, macrophage, and dentritic cells. We previously have reported a mAb termed sTA that recognizes the CD106 molecule on various TCR gamma delta T cell clones that do not proliferate in response to an anti-CD3 stimulation. In the present report, further biochemical analysis reveals two intracellular precursors (82 and 98 kDa) of the membrane-bound 110-kDa form of CD106. In addition, we detect a 100-kDa soluble form in the culture supernatant of the specific cloned lymphocytes. Phorbol ester raises the amount of the soluble CD106 in the supernatant while simultaneously inducing the disappearance of the membrane-bound form. We show that the membrane-anchored form of CD106 is converted to soluble form by a regulated proteolytic cleavage process involving a metalloprotease. EDTA and 1,10-phenanthroline, two potent inhibitors of metalloproteases, specifically inhibit the conversion of the membrane anchored to the soluble form of the CD106 molecule. In fact, these results implicate a Zn(2+)-activated metalloprotease in the regulation of CD106 expression in a subset of T cells and, therefore, represent a novel pathway of T cell functions.


This article has been cited by other articles:


Home page
J. Immunol.Home page
J. Giustiniani, A. Marie-Cardine, and A. Bensussan
A Soluble Form of the MHC Class I-Specific CD160 Receptor Is Released from Human Activated NK Lymphocytes and Inhibits Cell-Mediated Cytotoxicity
J. Immunol., February 1, 2007; 178(3): 1293 - 1300.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. Garcia-Touchard, T. D. Henry, G. Sangiorgi, L. G. Spagnoli, A. Mauriello, C. Conover, and R. S. Schwartz
Extracellular Proteases in Atherosclerosis and Restenosis
Arterioscler. Thromb. Vasc. Biol., June 1, 2005; 25(6): 1119 - 1127.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J. Liu, G. K. Sukhova, J.-S. Sun, W.-H. Xu, P. Libby, and G.-P. Shi
Lysosomal Cysteine Proteases in Atherosclerosis
Arterioscler. Thromb. Vasc. Biol., August 1, 2004; 24(8): 1359 - 1366.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. R. Worley, M. D. Baugh, D. A. Hughes, D. R. Edwards, A. Hogan, M. J. Sampson, and J. Gavrilovic
Metalloproteinase Expression in PMA-stimulated THP-1 Cells: EFFECTS OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-{gamma} (PPAR{gamma}) AGONISTS AND 9-CIS-RETINOIC ACID
J. Biol. Chem., December 19, 2003; 278(51): 51340 - 51346.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
V. Bailly, Z. Zhang, W. Meier, R. Cate, M. Sanicola, and J. V. Bonventre
Shedding of Kidney Injury Molecule-1, a Putative Adhesion Protein Involved in Renal Regeneration
J. Biol. Chem., October 11, 2002; 277(42): 39739 - 39748.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
C. M. Ballantyne and M. L. Entman
Soluble Adhesion Molecules and the Search for Biomarkers for Atherosclerosis
Circulation, August 13, 2002; 106(7): 766 - 767.
[Full Text] [PDF]


Home page
J. Exp. Med.Home page
M. Panigada, S. Porcellini, E. Barbier, S. Hoeflinger, P.-A. Cazenave, H. Gu, H. Band, H. von Boehmer, and F. Grassi
Constitutive Endocytosis and Degradation of the Pre-T Cell Receptor
J. Exp. Med., June 17, 2002; 195(12): 1585 - 1597.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
X. Wang, A. Kumanogoh, C. Watanabe, W. Shi, K. Yoshida, and H. Kikutani
Functional soluble CD100/Sema4D released from activated lymphocytes: possible role in normal and pathologic immune responses
Blood, June 1, 2001; 97(11): 3498 - 3504.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Elhabazi, S. Delaire, A. Bensussan, L. Boumsell, and G. Bismuth
Biological Activity of Soluble CD100. I. The Extracellular Region of CD100 Is Released from the Surface of T Lymphocytes by Regulated Proteolysis
J. Immunol., April 1, 2001; 166(7): 4341 - 4347.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
B. A. Kallmann, V. Hummel, T. Lindenlaub, K. Ruprecht, K. V. Toyka, and P. Rieckmann
Cytokine-induced modulation of cellular adhesion to human cerebral endothelial cells is mediated by soluble vascular cell adhesion molecule-1
Brain, April 1, 2000; 123(4): 687 - 697.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
T. Murase, N. Kume, H. Kataoka, M. Minami, T. Sawamura, T. Masaki, and T. Kita
Identification of Soluble Forms of Lectin-Like Oxidized LDL Receptor-1
Arterioscler. Thromb. Vasc. Biol., March 1, 2000; 20(3): 715 - 720.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
D. M. Rose, P. M. Cardarelli, R. R. Cobb, and M. H. Ginsberg
Soluble VCAM-1 binding to alpha 4 integrins is cell-type specific and activation dependent and is disrupted during apoptosis in T cells
Blood, January 15, 2000; 95(2): 602 - 609.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
G. A. Limb, J. Hickman-Casey, R. D. Hollifield, and A. H. Chignell
Vascular Adhesion Molecules in Vitreous from Eyes with Proliferative Diabetic Retinopathy
Invest. Ophthalmol. Vis. Sci., September 1, 1999; 40(10): 2453 - 2457.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
F. Grassi, E. Barbier, S. Porcellini, H. von Boehmer, and P.-A. Cazenave
Surface Expression and Functional Competence of CD3-Independent TCR {zeta}-Chains in Immature Thymocytes
J. Immunol., March 1, 1999; 162(5): 2589 - 2596.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J.-W. Oh, N. J. Van Wagoner, S. Rose-John, and E. N. Benveniste
Role of IL-6 and the Soluble IL-6 Receptor in Inhibition of VCAM-1 Gene Expression
J. Immunol., November 1, 1998; 161(9): 4992 - 4999.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. I. Chuang, B. A. Young, R. R. Thiagarajan, C. Cornejo, R. K. Winn, and J. M. Harlan
Cytoplasmic Domain of E-selectin Contains a Non-tyrosine Endocytosis Signal
J. Biol. Chem., October 3, 1997; 272(40): 24813 - 24818.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. V. Subramanian, M. L. Fitzgerald, and M. Bernfield
Regulated Shedding of Syndecan-1 and -4 Ectodomains by Thrombin and Growth Factor Receptor Activation
J. Biol. Chem., June 6, 1997; 272(23): 14713 - 14720.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Arribas, L. Coodly, P. Vollmer, T. K. Kishimoto, S. Rose-John, and J. Massagué
Diverse Cell Surface Protein Ectodomains Are Shed by a System Sensitive to Metalloprotease Inhibitors
J. Biol. Chem., May 10, 1996; 271(19): 11376 - 11382.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1995 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1995 by The American Association of Immunologists, Inc. All rights reserved.